BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fiorentino TV, Marini MA, Succurro E, Andreozzi F, Sesti G. Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage. BMJ Open Diabetes Res Care 2019;7:e000911. [PMID: 31798905 DOI: 10.1136/bmjdrc-2019-000911] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhao X, Wang Y, Chen R, Li J, Zhou J, Liu C, Zhou P, Sheng Z, Chen Y, Song L, Zhao H, Yan H. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study. Cardiovasc Diabetol 2021;20:131. [PMID: 34183007 DOI: 10.1186/s12933-021-01321-7] [Reference Citation Analysis]
2 Hu X, Li W, Wang C, Zhang H, Lu H, Li G, Zhou Y, Dong H. Association between the Plasma-Glycosylated Hemoglobin A1c/High-Density Lipoprotein Cholesterol Ratio and Carotid Atherosclerosis: A Retrospective Study. J Diabetes Res 2021;2021:9238566. [PMID: 34805413 DOI: 10.1155/2021/9238566] [Reference Citation Analysis]
3 Hu C, Zhang J, Liu J, Liu Y, Gao A, Zhu Y, Zhao Y. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China. Cardiovasc Diabetol 2020;19:116. [PMID: 32703284 DOI: 10.1186/s12933-020-01091-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Dong L, Lin M, Wang W, Ma D, Chen Y, Su W, Chen Z, Wang S, Li X, Li Z, Liu C. Lipid accumulation product (LAP) was independently associatedwith obstructive sleep apnea in patients with type 2 diabetes mellitus. BMC Endocr Disord 2020;20:179. [PMID: 33298050 DOI: 10.1186/s12902-020-00661-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Leite MM, Dutra MT, da Costa MVG, Funghetto SS, Silva AO, de Lima LR, da Silva ICR, Mota MR, Stival MM. Comparative evaluation of inflammatory parameters and substitute insulin resistance indices in elderly women with and without type 2 diabetes mellitus. Exp Gerontol 2021;150:111389. [PMID: 33957262 DOI: 10.1016/j.exger.2021.111389] [Reference Citation Analysis]
6 Wu Z, Zhou D, Liu Y, Li Z, Wang J, Han Z, Miao X, Liu X, Li X, Wang W, Guo X, Tao L. Association of TyG index and TG/HDL-C ratio with arterial stiffness progression in a non-normotensive population. Cardiovasc Diabetol 2021;20:134. [PMID: 34229681 DOI: 10.1186/s12933-021-01330-6] [Reference Citation Analysis]
7 Yu Y, Zhang FL, Yan XL, Zhang P, Guo ZN, Yang Y. Visceral adiposity index and cervical arterial atherosclerosis in northeast China: a population based cross-sectional survey. Eur J Neurol 2021;28:161-71. [PMID: 32896952 DOI: 10.1111/ene.14513] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Zhao X, Song L, Wang Y, Li J, Zhou J, Chen R, Liu C, Zhou P, Sheng Z, Chen Y, Zhao H, Yan H. Proprotein Convertase Subtilisin/Kexin Type 9 and Systemic Inflammatory Biomarker Pentraxin 3 for Risk Stratification Among STEMI Patients Undergoing Primary PCI. J Inflamm Res 2021;14:5319-35. [PMID: 34703271 DOI: 10.2147/JIR.S334246] [Reference Citation Analysis]
9 Gómez-Sánchez L, Gómez-Sánchez M, Lugones-Sánchez C, Tamayo-Morales O, González-Sánchez S, Rodríguez-Sánchez E, García-Ortiz L, Gómez-Marcos MA, On Behalf Of The Eva Investigators. Association of Insulin Resistance with Vascular Ageing in a General Caucasian Population: An EVA Study. J Clin Med 2021;10:5748. [PMID: 34945044 DOI: 10.3390/jcm10245748] [Reference Citation Analysis]
10 Caimi G, Urso C, Brucculeri S, Amato C, Carlisi M, Lo Presti R. An assessment of the hemorheological profile in patients with subclinical carotid atherosclerosis divided in relation to the number of cardiovascular risk factors and different degrees of insulin resistance. Clin Hemorheol Microcirc 2021. [PMID: 33843665 DOI: 10.3233/CH-211105] [Reference Citation Analysis]
11 Bermúdez V, Salazar J, Fuenmayor J, Nava M, Ortega Á, Duran P, Rojas M, Añez R, Rivas-Montenegro A, Angarita L, Chacín M, Cano C, Velasco M, Rojas J. Lipid Accumulation Product Is More Related to Insulin Resistance than the Visceral Adiposity Index in the Maracaibo City Population, Venezuela. J Obes 2021;2021:5514901. [PMID: 34194826 DOI: 10.1155/2021/5514901] [Reference Citation Analysis]
12 Anoop S S, Dasgupta R, Rebekah G, Jose A, Inbakumari MP, Finney G, Thomas N. Lipid accumulation product (LAP) as a potential index to predict risk of insulin resistance in young, non-obese Asian Indian males from Southern India: observations from hyperinsulinemic-euglycemic clamp studies. BMJ Open Diabetes Res Care 2021;9:e002414. [PMID: 34531243 DOI: 10.1136/bmjdrc-2021-002414] [Reference Citation Analysis]
13 Cardoso-Peña E, Soto Pina AE, Villanueva ÁG, López Chavez GE, Ramírez Martínez P, Ramírez Montoya H, Berumen Lechuga MG, Benitez Arciniega AD, Alarcón Fortepiani ML, Valdés Ramos R, Garduño García JJ. Visceral Adiposity Index in Breast Cancer Survivors: A Case-Control Study. Int J Endocrinol 2020;2020:8874916. [PMID: 33376488 DOI: 10.1155/2020/8874916] [Reference Citation Analysis]
14 Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, Zhou YJ. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol 2020;19:108. [PMID: 32641127 DOI: 10.1186/s12933-020-01086-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
15 Zhao Q, Cheng YJ, Xu YK, Zhao ZW, Liu C, Sun TN, Zhou YJ. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus. Cardiovasc Diabetol 2021;20:190. [PMID: 34537077 DOI: 10.1186/s12933-021-01383-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Li M, Zhan A, Huang X, Hu L, Zhou W, Wang T, Zhu L, Bao H, Cheng X. Positive association between triglyceride glucose index and arterial stiffness in hypertensive patients: the China H-type Hypertension Registry Study. Cardiovasc Diabetol 2020;19:139. [PMID: 32948181 DOI: 10.1186/s12933-020-01124-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
17 Zhao Q, Cheng YJ, Xu YK, Zhao ZW, Liu C, Sun TN, Zhou YJ. Visceral Adiposity Index Plays an Important Role in Prognostic Prediction in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome and Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention. Front Cardiovasc Med 2021;8:735637. [PMID: 34869637 DOI: 10.3389/fcvm.2021.735637] [Reference Citation Analysis]
18 Su Y, Wang S, Sun J, Zhang Y, Ma S, Li M, Zhang A, Cheng B, Cai S, Bao Q, Zhu P. Triglyceride Glucose Index Associated With Arterial Stiffness in Chinese Community-Dwelling Elderly. Front Cardiovasc Med 2021;8:737899. [PMID: 34589530 DOI: 10.3389/fcvm.2021.737899] [Reference Citation Analysis]
19 Miroslawska AK, Gjessing PF, Solbu MD, Norvik JV, Fuskevåg OM, Hanssen TA, Steigen TK. Metabolic effects two years after renal denervation in insulin resistant hypertensive patients. The Re-Shape CV-risk study. Clin Nutr 2021;40:1503-9. [PMID: 33743285 DOI: 10.1016/j.clnu.2021.02.027] [Reference Citation Analysis]
20 Wu Z, Wang J, Li Z, Han Z, Miao X, Liu X, Li X, Wang W, Guo X, Tao L. Triglyceride glucose index and carotid atherosclerosis incidence in the Chinese population: A prospective cohort study. Nutr Metab Cardiovasc Dis 2021;31:2042-50. [PMID: 34045133 DOI: 10.1016/j.numecd.2021.03.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Chen Y, Peng A, Chen Y, Kong X, Li L, Tang G, Li H, Chen Y, Jiang F, Li P, Zhang Q. Association of TyG Index with CT Features in Patients with Tuberculosis and Diabetes Mellitus. IDR 2022;Volume 15:111-25. [DOI: 10.2147/idr.s347089] [Reference Citation Analysis]
22 Zhu Y, Liu K, Chen M, Liu Y, Gao A, Hu C, Li H, Zhu H, Han H, Zhang J, Zhao Y. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents. Cardiovasc Diabetol 2021;20:137. [PMID: 34238294 DOI: 10.1186/s12933-021-01332-4] [Reference Citation Analysis]
23 Radellini S, Vigneri E, Guarnotta V, Panto F, Giordano C. One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus. Diabetes Ther 2021;12:1677-88. [PMID: 33928530 DOI: 10.1007/s13300-021-01056-4] [Reference Citation Analysis]
24 Park HM, Lee HS, Lee YJ, Lee JH. The triglyceride-glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance. Diabetes Res Clin Pract 2021;180:109042. [PMID: 34506839 DOI: 10.1016/j.diabres.2021.109042] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]